Future of Precision Medicine Symposium 2023
As part of the Novo Nordisk Foundation’s precision medicine initiatives, the two-day Future of Preci-sion Medicine Symposium 2023 featured lectures and panel discussions on within a broad array – from major innovations in precision diabetes medicine to cutting-edge research through clinical imple-mentation.
The discovery of insulin 100 years ago was a true breakthrough and lifesaver in the treatment of peo-ple with diabetes. However, despite being around for a century, insulin and other means of treatment, often deployed in a one-size-fits-all manner, still fail to take most people to a level of control that nor-malizes morbidity and mortality. Precision medicine, the tailoring of disease prevention and treatment strategies based on an individual’s genetics and other biomarkers, lifestyle and environment, aims at doing just that, by helping optimise medical decisions.
The symposium also celebrated the winner of the EFSD and Novo Nordisk Foundation Precision Diabe-tes Medicine Award. The award honours innovative research in both clinical and basic science that is likely to minimise the future burden of diabetes and other chronic diseases.
See the full programme for the Future Precision Medicine Symposium 2023 below.
Thursday, 9 November
Official opening
Welcome and opening remarks
By Senior Vice President Martin Ridderstråle, the Novo Nordisk Foundation & President Chantal Mathieu, the EFSD/EASD
Click here
Diabetes: The lived experience. Introduced by people living with diabetes
Panelists:
- Christian Collin
- Sophie Hindkjær
- Maria Tørnes
- Cathrine Tørnes
Facilitated by: Director Jeanette Söderberg, JDRF International
Click here
What the heck is “precision medicine”?
Interview with Director Paul Franks, Novo Nordisk Foundation
Interviewed by:
- President Chantal Mathieu, the EFSD/EASD
- Person living with diabetes Christian Collin
Theme I: Translating Precision Medicine Evidence into Practice
Monogenic insulin resistance
Lecture by Professor Robert Semple, University of Edinburgh
Click here
Ensuring correct diagnosis and treatment of monogenic diabetes across the UK
Lecture by Professor and Nurse specialist Maggie Shepherd, University of Exeter
Click here
Clinical impact on cardiometabolic disease through liver-focused precision medicine
Lecture by Professor, Dr. Arun Sanyal, Virginia Commonwealth University
Click here
Q&A
Facilitated by:
- Person living with diabetes Maria Tørnes
- Professor Juleen Zierath, Novo Nordisk Foundation Center for Basic Metabolic Research and Karolinska Institutet
Theme II: Getting to the heart of precision medicine
Precision medicine decision making in cardiomyopathy
Lecture by Professor Perry Elliott, the Bart’s Heart Centre
Click here
Precision medicine in the future of CVD prevention
Lecture by Scientific Director Borja Ibanez, the Centro Nacional de Investigaciones Cardiovasculares Carlos III
Click here
Clinical translation of discordant profiles in cardiometabolic conditions
Lecture by Dr. Daniel Coral, Lund University
Click here
Q&A
Facilitated by:
- CEO Magnus T. Jensen, Steno Diabetes Center Copenhagen
- Person living with diabetes Sophie Hindkjær
Theme III: The 2nd International Consensus Report from the ADA/EASD Precision Medicine in Diabetes Initiative
The 2nd International Consensus Report presented by:
- Clinical Investigator PhD, MD Mario Luca Morieri, University Hospital of Padua
- Associate Professor Jordi Merino, Novo Nordisk Foundation Center for Basic Metabolic Research
Panel debate
Panelists:
- Clinical Investigator PhD, MD Mario Luca Morieri, University Hospital of Padua
- Associate Professor Jordi Merino, Novo Nordisk Foundation Center for Basic Metabolic Re-search
- Professor Susanne Mandrup, University of Southern Denmark
- Chief Editor Joao Monteiro, Nature Medicine
- CEO Troels Krarup Hansen, Steno Diabetes Center Aarhus
Facilitated by:
- Professor Juleen Zierath, Novo Nordisk Foundation Center for Basic Metabolic Research and Karolinska Institutet
- Person living with diabetes Christian Collin
Award Ceremony: The EFSD and the Novo Nordisk Foundation Precision Diabetes Medicine Award 2023
Opening remarks by chair: Professor Coen D.A. Stehouwer, Chairperson EFSD Scientific Board
Click here
Using precision medicine tools to advance understanding of type 2 diabetes risk in the south Asian population
Prize Lecture by Dr. Shivani Misra, Imperial College London
Click here
Q&A
Facilitated by:
- Professor Coen D.A. Stehouwer, Chairperson EFSD Scientific Board
- Person living with diabetes Sophie Hindkjær
Friday, 10 November
Theme IV: The human interface
Intervening on human health behaviour
Lecture by Professor Joline Beulens, Vrije University
Click here
AI in medical decision making
Lecture by Assistant Professor Pranav Rajpurkar, Harvard Medical Schoo
Click here
Medical psychologists can help achieving precision medicine
Lecture by Professor Frans Pouwer, University of Southern Denmark
Click here
Q&A
Facilitated by:
- Person living with diabetes Sophie Hindkjær
- Director Paul Franks, the Novo Nordisk Foundation
Theme V: Precision healthcare for the people who really need it
Leveraging African genetic diversity for novel gene discovery & genetic risk prediction
Lecture by Associate Professor, PhD Segun Fatumo, London School of Hygiene & Tropical Medicine
Click here
Precision medicine in underserved populations in high-income countries
Lecture by Dr. Shivani Misra, Imperial College London
Click here
Precision medicine in low- and middle-income countries
Lecture by Dr. Tinashe Chikowore, University of the Witwatersrand
Click here
Moving from identifying the disparities to creating a new community-based precision medicine platform
Lecture by Dr. Sivan Spitzer, Bar-Ilan University, Bar-Ilan University
Click here
Q&A
Facilitated by:
- Person living with diabetes Maria Tørnes
- Senior Vice President Martin Ridderstråle, the Novo Nordisk Foundation
Official closing
Closing remarks
By:
- Person living with diabetes Christian Collin
- President Chantal Mathieu, the EFSD/EASD
- Director Paul Franks, the Novo Nordisk Foundation
